Fineline Cube

Follow:
14487 Articles
Jiangxi Institute of Biological Products Files for Hong Kong IPO Amid Strong Market Position
CompanyDeals

Jiangxi Institute of Biological Products Files for Hong Kong IPO Amid Strong Market Position

Zhaoke Ophthalmology Launches Phase II Study for Brimochol PF in Presbyopia Treatment
CompanyDeals

Zhaoke Ophthalmology Launches Phase II Study for Brimochol PF in Presbyopia Treatment

CSPC Pharmaceutical Gains NMPA Approval for Clinical Trial of SYH2046 in Heart Failure
CompanyDrug

CSPC Pharmaceutical Gains NMPA Approval for Clinical Trial of SYH2046 in Heart Failure

Amgen's Imdelltra Shows Positive Phase III Results in Small Cell Lung Cancer
CompanyDrug

Amgen’s Imdelltra Shows Positive Phase III Results in Small Cell Lung Cancer

Shanghai Microport EP Medtech Secures NMPA Fast-Track Designation for EasyEcho Catheter
CompanyMedical Device

Shanghai Microport EP Medtech Secures NMPA Fast-Track Designation for EasyEcho Catheter

Jiangsu Hengrui Secures NMPA Approval for Clinical Trials of SHR-3792 and HRS-9190
CompanyDrug

Jiangsu Hengrui Secures NMPA Approval for Clinical Trials of SHR-3792 and HRS-9190

Johnson & Johnson Launches Rybrevant in China for EGFR Exon 20 Insertion Mutation Lung Cancer
CompanyDrug

Johnson & Johnson Launches Rybrevant in China for EGFR Exon 20 Insertion Mutation Lung Cancer

Tasly Pharma Gains NMPA Green Light for CAR-T Therapy Clinical Study in Recurrent Glioblastoma
CompanyDrug

Tasly Pharma Gains NMPA Green Light for CAR-T Therapy Clinical Study in Recurrent Glioblastoma

CR Boya Gains NMPA Approval for Clinical Trials of Subcutaneous Human Immunoglobulin
CompanyDrug

CR Boya Gains NMPA Approval for Clinical Trials of Subcutaneous Human Immunoglobulin

Novartis Announces USD 23 Billion Investment to Expand U.S. Manufacturing and R&D Hubs
Company

Novartis Announces USD 23 Billion Investment to Expand U.S. Manufacturing and R&D Hubs

Juventas Cell Therapy Secures China Clinical Trial Approval for Inaticabtagene Autoleucel in AIHA
CompanyDrug

Juventas Cell Therapy Secures China Clinical Trial Approval for Inaticabtagene Autoleucel in AIHA

Belief BioMed and Takeda Win NMPA Approval for China's First Hemophilia B Gene Therapy
CompanyDrug

Belief BioMed and Takeda Win NMPA Approval for China’s First Hemophilia B Gene Therapy